Vanda’s Sleep Disorder Drug Tasimelteon Shows Promise
The experimental drug tasimelteon has passed its second late-stage trial with surprisingly good results, showing the effectiveness of the drug in treating a rare condition called non-24-hour sleep-wake disorder (non-24)...Prostate Cancer Diagnoses Up, Deaths Down, Latest UK Figures Gene Associated With Schizophrenia Identified
